126 related articles for article (PubMed ID: 1918421)
1. Placebo-controlled trial of venlafaxine for the treatment of major depression.
Schweizer E; Weise C; Clary C; Fox I; Rickels K
J Clin Psychopharmacol; 1991 Aug; 11(4):233-6. PubMed ID: 1918421
[TBL] [Abstract][Full Text] [Related]
2. Comparison of venlafaxine and imipramine in the acute treatment of major depression in outpatients.
Schweizer E; Feighner J; Mandos LA; Rickels K
J Clin Psychiatry; 1994 Mar; 55(3):104-8. PubMed ID: 8071246
[TBL] [Abstract][Full Text] [Related]
3. A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder.
Perahia DG; Pritchett YL; Kajdasz DK; Bauer M; Jain R; Russell JM; Walker DJ; Spencer KA; Froud DM; Raskin J; Thase ME
J Psychiatr Res; 2008 Jan; 42(1):22-34. PubMed ID: 17445831
[TBL] [Abstract][Full Text] [Related]
4. Venlafaxine in depressed outpatients.
Khan A; Fabre LF; Rudolph R
Psychopharmacol Bull; 1991; 27(2):141-4. PubMed ID: 1924660
[TBL] [Abstract][Full Text] [Related]
5. A double-blind, placebo-controlled evaluation of the effects of orally administered venlafaxine on sleep in inpatients with major depression.
Luthringer R; Toussaint M; Schaltenbrand N; Bailey P; Danjou PH; Hackett D; Guichoux JY; Macher JP
Psychopharmacol Bull; 1996; 32(4):637-46. PubMed ID: 8993085
[TBL] [Abstract][Full Text] [Related]
6. Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.
Hewett K; Chrzanowski W; Schmitz M; Savela A; Milanova V; Gee M; Krishen A; Millen L; Leary MO; Modell J
J Psychopharmacol; 2009 Jul; 23(5):531-8. PubMed ID: 18635695
[TBL] [Abstract][Full Text] [Related]
7. A randomized, double-blind, placebo-controlled trial of desvenlafaxine succinate in the treatment of major depressive disorder.
Septien-Velez L; Pitrosky B; Padmanabhan SK; Germain JM; Tourian KA
Int Clin Psychopharmacol; 2007 Nov; 22(6):338-47. PubMed ID: 17917552
[TBL] [Abstract][Full Text] [Related]
8. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
[TBL] [Abstract][Full Text] [Related]
9. A comparison of venlafaxine, trazodone, and placebo in major depression.
Cunningham LA; Borison RL; Carman JS; Chouinard G; Crowder JE; Diamond BI; Fischer DE; Hearst E
J Clin Psychopharmacol; 1994 Apr; 14(2):99-106. PubMed ID: 8195464
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of b.i.d. doses of venlafaxine in a dose-response study.
Mendels J; Johnston R; Mattes J; Riesenberg R
Psychopharmacol Bull; 1993; 29(2):169-74. PubMed ID: 8290661
[TBL] [Abstract][Full Text] [Related]
11. A double-blind, placebo-controlled comparison of venlafaxine and fluoxetine treatment in depressed outpatients.
Nemeroff CB; Thase ME;
J Psychiatr Res; 2007; 41(3-4):351-9. PubMed ID: 16165158
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of venlafaxine in geriatric outpatients with major depression: a double-blind, randomised 6-month comparative trial with citalopram.
Allard P; Gram L; Timdahl K; Behnke K; Hanson M; Søgaard J
Int J Geriatr Psychiatry; 2004 Dec; 19(12):1123-30. PubMed ID: 15526307
[TBL] [Abstract][Full Text] [Related]
13. A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.
Pollack MH; Lepola U; Koponen H; Simon NM; Worthington JJ; Emilien G; Tzanis E; Salinas E; Whitaker T; Gao B
Depress Anxiety; 2007; 24(1):1-14. PubMed ID: 16894619
[TBL] [Abstract][Full Text] [Related]
14. The role of venlafaxine in rational antidepressant therapy.
Feighner JP
J Clin Psychiatry; 1994 Sep; 55 Suppl A():62-8; discussion 69-70, 98-100. PubMed ID: 7961545
[TBL] [Abstract][Full Text] [Related]
15. Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms.
Davidson JR; Meoni P; Haudiquet V; Cantillon M; Hackett D
Depress Anxiety; 2002; 16(1):4-13. PubMed ID: 12203668
[TBL] [Abstract][Full Text] [Related]
16. Milnacipran and pindolol: a randomized trial of reduction of antidepressant latency.
Isaac MT; Isaac MB; Gallo F; Tournoux A
Hum Psychopharmacol; 2003 Dec; 18(8):595-601. PubMed ID: 14696018
[TBL] [Abstract][Full Text] [Related]
17. Subchronic antidepressant treatment with venlafaxine or imipramine and effects on blood pressure and heart rate: assessment by automatic 24-hour monitoring.
Gründer G; Wetzel H; Schlösser R; Benkert O
Pharmacopsychiatry; 1996 Mar; 29(2):72-8. PubMed ID: 8741025
[TBL] [Abstract][Full Text] [Related]
18. A double-blind, placebo-controlled trial of two dose ranges of nefazodone in the treatment of depressed outpatients.
Mendels J; Reimherr F; Marcus RN; Roberts DL; Francis RJ; Anton SF
J Clin Psychiatry; 1995; 56 Suppl 6():30-6. PubMed ID: 7649971
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of Venlafaxine ER in patients with social anxiety disorder: a double-blind, placebo-controlled, parallel-group comparison with paroxetine.
Allgulander C; Mangano R; Zhang J; Dahl AA; Lepola U; Sjödin I; Emilien G;
Hum Psychopharmacol; 2004 Aug; 19(6):387-96. PubMed ID: 15303242
[TBL] [Abstract][Full Text] [Related]
20. Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial.
Jahn H; Schick M; Kiefer F; Kellner M; Yassouridis A; Wiedemann K
Arch Gen Psychiatry; 2004 Dec; 61(12):1235-44. PubMed ID: 15583115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
